avapro has been researched along with Pulmonary Disease, Chronic Obstructive in 4 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhafez, AT | 1 |
| Gomaa, AMS | 1 |
| Ahmed, AM | 1 |
| Sayed, MM | 1 |
| Ahmed, MA | 1 |
| Marquis, K | 1 |
| Maltais, F | 1 |
| Lacasse, Y | 1 |
| Lacourciere, Y | 1 |
| Fortin, C | 1 |
| Poirier, P | 1 |
| Raupach, T | 2 |
| Lüthje, L | 2 |
| Kögler, H | 1 |
| Duve, C | 1 |
| Schweda, F | 1 |
| Hasenfuss, G | 2 |
| Andreas, S | 2 |
| Herrmann-Lingen, C | 1 |
| Fabricius, JA | 1 |
| Hruska, N | 1 |
| Körber, W | 1 |
| Büchner, B | 1 |
| Criée, CP | 1 |
| Calverley, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| ACE-inhibition and Mechanisms of Skeletal Muscle Weakness in Chronic Obstructive Pulmonary Disease[NCT01014338] | Phase 4 | 80 participants (Actual) | Interventional | 2009-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for avapro and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Effects of aerobic exercise training and irbesartan on blood pressure and heart rate variability in patients with chronic obstructive pulmonary disease.
Topics: Aged; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Blood Pressure; B | 2008 |
Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Double-Blind Method; Female; Humans; Ir | 2006 |
2 other studies available for avapro and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Pioglitazone and/or irbesartan ameliorate COPD-induced endothelial dysfunction in side stream cigarette smoke-exposed mice model.
Topics: Animals; Antihypertensive Agents; Cigarette Smoking; Disease Models, Animal; Endothelium; Hypoglycem | 2021 |
Local and systemic effects of angiotensin receptor blockade in an emphysema mouse model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biomechanical Phenomena; Biphenyl Compounds; Disea | 2011 |